drug sales are forecast to rise by a third in five years, vaccine sales should double, from $19 billion last year to $39 billion in 2013, according to market research firm Kalorama Information. That’s five times the $8 billion in vaccine sales in 2004.
– Malaria. Tuberculosis. Alzheimer’s disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler’s diarrhea.
You name it, the pharmaceutical industry is working on a vaccine to prevent it.
Click on the following for more details: Business Journal | Vaccines on horizon for AIDS, Alzheimer’s, herpes